medicinal oxygen air liquide sante
air liquide santé international - oxígeno - todos los demás productos terapéuticos - horses; dogs; cats - para suplementos de oxígeno y como gas portador durante la inhalación de anestesia. para la administración de suplementos de oxígeno durante la recuperación.
oxigeno medicinal liquido solgroup 99,5% v/v gas para inhalacion
sol s.p.a. - oxigeno - gas criogÉnico medicinal - 99,5 % v/v - oxigeno 99.5 % v/v - oxígeno
oxygenor tableta 30.0 mg
laboratorios quimifar s.a. de c.v. - tabletas - 30.0 mg
oxygenor tableta recubierta 30 mg
laboratorios quimifar s.a. de c.v. - tabletas recubiertas - 30 mg
diclofenaco 100 mg tableta de liberacion prolongada
instituto quimioterapico s.a. - diclofenaco de sodio; - tableta de liberacion prolongada - por tableta - diclofenaco
kineret
swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - inmunosupresores - la artritis reumatoide (ar)kineret está indicado en adultos para el tratamiento de los signos y síntomas de la ar en combinación con metotrexato, con una respuesta inadecuada a metotrexato solo. covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml. periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret debe administrarse en combinación con colchicina, si es apropiado. still’s diseasekineret is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of still’s disease, including systemic juvenile idiopathic arthritis (sjia) and adult-onset still’s disease (aosd), with active systemic features of moderate to high disease activity, or in patients with continued disease activity after treatment with non-steroidal anti-inflammatory drugs (nsaids) or glucocorticoids. kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
oxigeno medicinal liquido solspa 99,5 % v/v gas para la inhalacion
sol s.p.a. - oxigeno - gas criogÉnico medicinal - 99,5% v/v - oxigeno 99.5 % v/v - oxígeno
oxigeno medicinal gas solgroup 99,5% v/v gas para inhalacion
sol s.p.a. - oxigeno - gas comprimido medicinal - 99,5% v/v - oxigeno 99,5 % v/v - oxígeno
oxygenor 10 mg/50 ml solución para infusión
laboratorios quimifar s.a. de c.v. - solución para infusión - 10 mg/50 ml